Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 1/2020

22.11.2019 | Original Article – Cancer Research

Candidate lncRNA–miRNA–mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis

verfasst von: Rui Zhang, Ying-yi Jiang, Kun Xiao, Xiao-quan Huang, Jian Wang, Shi-yao Chen

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to explore the potential competing endogenous RNA (ceRNA) network in forecasting HCC development in patients with cirrhosis through a comprehensive bioinformatic analysis.

Methods

Data mining from GEO and TCGA databases was employed to dig a spectrum of differentially expressed mRNA, lncRNA and miRNA profiles. Their expression was confirmed by RT-PCR in matched HCC cohorts (n = 6/group). The ceRNA network was constructed by co-expression analysis. Their reciprocal regulations and their roles in epithelial-to-mesenchymal transition (EMT) process were validated by gain- and loss-of-function experiments at the cellular level. Kaplan–Meier method was applied to reveal prognostic values.

Results

By intersecting differentially expressed genes (DEGs) in GEO and TCGA data sets and Pearson correlation analysis, 20 mRNAs, 24 miRNAs and 41 lncRNAs were identified. Of these, FOXD2-AS1, BLVRA and CYTH2 were markedly upregulated in HCC tissues and HCC cells with high metastatic potential (MHCC97H) compared with their adjacent normal/cirrhotic tissues and L02 and MHCC97L cells. However, dysregulated miR-139-5p exhibited the opposite expression pattern. Using miRanda algorithms, FOXD2-AS1, BLVRA and CYTH2 showed potential binding sites for miR-139-5p. FOXD2-AS1 knockdown induced a marked increase in miR-139-5p and EMT inhibition. The loss of miR-139-5p led to an increase in BLVRA and CYTH2 expression and EMT process. Conversely, miR-139-5p overexpression suppressed BLVRA and CYTH expression and EMT process. FOXD2-AS1, miR-139-5p, BLVRA and CYTH2 highly correlated with prognosis in patients with HCC.

Conclusion

FOXD2-AS1/miR-139-5p/BLVRA or CYTH2 axis might be the underlying molecular mechanism that dissects HCC development caused by cirrhosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Ashburner M, Ball CA, Blake JA et al (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25(1):25–29CrossRef Ashburner M, Ball CA, Blake JA et al (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25(1):25–29CrossRef
Zurück zum Zitat Barrett T, Suzek TO, Troup DB et al (2005) NCBI GEO: mining millions of expression profiles—database and tools. Nucleic Acids Res 33(suppl 1):D562–D566PubMed Barrett T, Suzek TO, Troup DB et al (2005) NCBI GEO: mining millions of expression profiles—database and tools. Nucleic Acids Res 33(suppl 1):D562–D566PubMed
Zurück zum Zitat Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57:289–300 Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57:289–300
Zurück zum Zitat Borzio M, Bruno S, Roncalli M et al (1995) Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 108(3):812–817CrossRef Borzio M, Bruno S, Roncalli M et al (1995) Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 108(3):812–817CrossRef
Zurück zum Zitat Carleton M, Cleary MA, Linsley PS (2007) MicroRNAs and cell cycle regulation. Cell Cycle 6:2127–2132CrossRef Carleton M, Cleary MA, Linsley PS (2007) MicroRNAs and cell cycle regulation. Cell Cycle 6:2127–2132CrossRef
Zurück zum Zitat Chen T, Chen J, Zhu Y et al (2019) CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2. Oncogene 38(8):1183–1199CrossRef Chen T, Chen J, Zhu Y et al (2019) CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2. Oncogene 38(8):1183–1199CrossRef
Zurück zum Zitat Donato MF, Arosio E, Del Ninno E et al (2001) High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology 34(3):523–528CrossRef Donato MF, Arosio E, Del Ninno E et al (2001) High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology 34(3):523–528CrossRef
Zurück zum Zitat El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576CrossRef El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576CrossRef
Zurück zum Zitat European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef
Zurück zum Zitat Fan H, Lv P, Mu T et al (2018) LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells. Cancer Lett 429:89–99CrossRef Fan H, Lv P, Mu T et al (2018) LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells. Cancer Lett 429:89–99CrossRef
Zurück zum Zitat Fattovich G, Stroffolini T, Zagni I et al (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127(5, Suppl 1):S35–S50CrossRef Fattovich G, Stroffolini T, Zagni I et al (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127(5, Suppl 1):S35–S50CrossRef
Zurück zum Zitat Fu N, Niu X, Wang Y et al (2016) Role of LncRNA-activated by transforming growth factor beta in the progression of hepatitis C virus-related liver fibrosis. Discov Med 22(119):29–42PubMed Fu N, Niu X, Wang Y et al (2016) Role of LncRNA-activated by transforming growth factor beta in the progression of hepatitis C virus-related liver fibrosis. Discov Med 22(119):29–42PubMed
Zurück zum Zitat Han X, Hong Y, Zhang K (2018) TUG1 is involved in liver fibrosis and activation of HSCs by regulating miR-29b. Biochem Biophys Res Commun 503(3):1394–1400CrossRef Han X, Hong Y, Zhang K (2018) TUG1 is involved in liver fibrosis and activation of HSCs by regulating miR-29b. Biochem Biophys Res Commun 503(3):1394–1400CrossRef
Zurück zum Zitat Hanson A, Wilhelmsen D, DiStefano JK (2018) The role of long non-coding RNAs (lncRNAs) in the development and progression of fibrosis associated with nonalcoholic fatty liver disease (NAFLD). Noncoding RNA 4(3):18PubMedCentral Hanson A, Wilhelmsen D, DiStefano JK (2018) The role of long non-coding RNAs (lncRNAs) in the development and progression of fibrosis associated with nonalcoholic fatty liver disease (NAFLD). Noncoding RNA 4(3):18PubMedCentral
Zurück zum Zitat Hua S, Lei L, Deng L et al (2018) miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene 37(12):1624–1636CrossRef Hua S, Lei L, Deng L et al (2018) miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene 37(12):1624–1636CrossRef
Zurück zum Zitat Huang Y, Xiang B, Liu Y et al (2018) LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis. Cancer Lett 437:56–66CrossRef Huang Y, Xiang B, Liu Y et al (2018) LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis. Cancer Lett 437:56–66CrossRef
Zurück zum Zitat Hucke F, Sieghart W, Schoniger-Hekele M et al (2011) Clinical characteristics of patients with hepatocellular carcinoma in Austria—is there a need for a structured screening program? Wien Klin Wochenschr 123:542–551CrossRef Hucke F, Sieghart W, Schoniger-Hekele M et al (2011) Clinical characteristics of patients with hepatocellular carcinoma in Austria—is there a need for a structured screening program? Wien Klin Wochenschr 123:542–551CrossRef
Zurück zum Zitat Jia Y, Han S, Li J et al (2017) IRF8 is the target of SIRT1 for the inflammation response in macrophages. Innate Immun 23(2):188–195CrossRef Jia Y, Han S, Li J et al (2017) IRF8 is the target of SIRT1 for the inflammation response in macrophages. Innate Immun 23(2):188–195CrossRef
Zurück zum Zitat Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27–30CrossRef Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27–30CrossRef
Zurück zum Zitat Kubícková KN, Subhanová I, Konícková R et al (2016) Predictive role BLVRA mRNA expression in hepatocellular cancer. Ann Hepatol 15(6):881–887PubMed Kubícková KN, Subhanová I, Konícková R et al (2016) Predictive role BLVRA mRNA expression in hepatocellular cancer. Ann Hepatol 15(6):881–887PubMed
Zurück zum Zitat Kumar L, Futschik ME (2007) Mfuzz: a software package for soft clustering of microarray data. Bioinformation 2(1):5–7CrossRef Kumar L, Futschik ME (2007) Mfuzz: a software package for soft clustering of microarray data. Bioinformation 2(1):5–7CrossRef
Zurück zum Zitat Lendvai G, Szekerczés T, Gyöngyösi B et al (2019) MicroRNA expression in focal nodular hyperplasia in comparison with cirrhosis and hepatocellular carcinoma. Pathol Oncol Res 25(3):1103–1109CrossRef Lendvai G, Szekerczés T, Gyöngyösi B et al (2019) MicroRNA expression in focal nodular hyperplasia in comparison with cirrhosis and hepatocellular carcinoma. Pathol Oncol Res 25(3):1103–1109CrossRef
Zurück zum Zitat Mo Y, He L, Lai Z et al (2018) LINC01287/miR-298/STAT3 feedback loop regulates growth and the epithelial-to-mesenchymal transition phenotype in hepatocellular carcinoma cells. J Exp Clin Cancer Res 37(1):149CrossRef Mo Y, He L, Lai Z et al (2018) LINC01287/miR-298/STAT3 feedback loop regulates growth and the epithelial-to-mesenchymal transition phenotype in hepatocellular carcinoma cells. J Exp Clin Cancer Res 37(1):149CrossRef
Zurück zum Zitat Qi X, Zhang DH, Wu N et al (2015) ceRNA in cancer: possible functions and clinical implications. J Med Genet 52(10):710–718CrossRef Qi X, Zhang DH, Wu N et al (2015) ceRNA in cancer: possible functions and clinical implications. J Med Genet 52(10):710–718CrossRef
Zurück zum Zitat Salmena L, Poliseno L, Tay Y et al (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146:353–358CrossRef Salmena L, Poliseno L, Tay Y et al (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146:353–358CrossRef
Zurück zum Zitat Sana J, Faltejskova P, Svoboda M et al (2012) Novel classes of non-coding RNAs and cancer. J Transl Med 10:103CrossRef Sana J, Faltejskova P, Svoboda M et al (2012) Novel classes of non-coding RNAs and cancer. J Transl Med 10:103CrossRef
Zurück zum Zitat Sato M, Ikeda H, Uranbileg B et al (2016) Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human. Sci Rep 6:32119CrossRef Sato M, Ikeda H, Uranbileg B et al (2016) Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human. Sci Rep 6:32119CrossRef
Zurück zum Zitat Schrader J, Gordon-Walker TT, Aucott RL et al (2011) Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology 53(4):1192–1205CrossRef Schrader J, Gordon-Walker TT, Aucott RL et al (2011) Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology 53(4):1192–1205CrossRef
Zurück zum Zitat Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504CrossRef Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504CrossRef
Zurück zum Zitat Sharma MC (2019) Annexin A2 (ANXA2): an emerging biomarker and potential therapeutic target for aggressive cancers. Int J Cancer 144(9):2074–2081CrossRef Sharma MC (2019) Annexin A2 (ANXA2): an emerging biomarker and potential therapeutic target for aggressive cancers. Int J Cancer 144(9):2074–2081CrossRef
Zurück zum Zitat Smyth GK. Limma: linear models for microarray data. In: Bioinformatics & computational biology solutions using R & Bioconductor 2011:397–420 Smyth GK. Limma: linear models for microarray data. In: Bioinformatics & computational biology solutions using R & Bioconductor 2011:397–420
Zurück zum Zitat Tang Y, Li M, Wang J et al (2015) CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. BioSystems 127:67–72CrossRef Tang Y, Li M, Wang J et al (2015) CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. BioSystems 127:67–72CrossRef
Zurück zum Zitat Wu MS, Wang CH, Tseng FC et al (2017) Interleukin-17F expression is elevated in hepatitis C patients with fibrosis and hepatocellular carcinoma. Infect Agent Cancer 12:42CrossRef Wu MS, Wang CH, Tseng FC et al (2017) Interleukin-17F expression is elevated in hepatitis C patients with fibrosis and hepatocellular carcinoma. Infect Agent Cancer 12:42CrossRef
Zurück zum Zitat Xu K, Zhang Z, Qian J et al (2019) LncRNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma through epigenetically silencing CDKN1B (p27) via EZH2. Exp Cell Res 380(2):198–204CrossRef Xu K, Zhang Z, Qian J et al (2019) LncRNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma through epigenetically silencing CDKN1B (p27) via EZH2. Exp Cell Res 380(2):198–204CrossRef
Zurück zum Zitat Yeung TL, Tsai CC, Leung CS et al (2018) ISG15 promotes ERK1 ISGylation, CD8+ T cell activation and suppresses ovarian cancer progression. Cancers (Basel) 10(12):464CrossRef Yeung TL, Tsai CC, Leung CS et al (2018) ISG15 promotes ERK1 ISGylation, CD8+ T cell activation and suppresses ovarian cancer progression. Cancers (Basel) 10(12):464CrossRef
Zurück zum Zitat Zhang K, Shi ZM, Chang YN et al (2014) The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene 547:1–9CrossRef Zhang K, Shi ZM, Chang YN et al (2014) The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene 547:1–9CrossRef
Zurück zum Zitat Zhang Z, Wang S, Liu W (2018) EMT-related long non-coding RNA in hepatocellular carcinoma: a study with TCGA database. Biochem Biophys Res Commun 503(3):1530–1536CrossRef Zhang Z, Wang S, Liu W (2018) EMT-related long non-coding RNA in hepatocellular carcinoma: a study with TCGA database. Biochem Biophys Res Commun 503(3):1530–1536CrossRef
Metadaten
Titel
Candidate lncRNA–miRNA–mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis
verfasst von
Rui Zhang
Ying-yi Jiang
Kun Xiao
Xiao-quan Huang
Jian Wang
Shi-yao Chen
Publikationsdatum
22.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 1/2020
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-019-03090-z

Weitere Artikel der Ausgabe 1/2020

Journal of Cancer Research and Clinical Oncology 1/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.